drugset / Trial / NCT02111473

The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism

NCT02111473

Phase 4 Completed 49 enrolled Gulhane School of Medicine
NaSingle-groupOpen-labelTreatment

Summary

The study is designed to answer the following questions: 1\) What is the effect of testosteron replacement treatment on the endothelial dysfunction. 2/ What is the effect of testosteron replacement on the bone mineral metabolism.

Timeline

Start
2009-05
Primary completion
2012-05
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 250 mg Other

Indications